• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER SWITZERLAND MANUFACTURING GMBH DURASUL, ALPHA INSERT, GG/32; INTER-OP DURASUL ACETAB INSE/COCR FEMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER SWITZERLAND MANUFACTURING GMBH DURASUL, ALPHA INSERT, GG/32; INTER-OP DURASUL ACETAB INSE/COCR FEMOR Back to Search Results
Model Number N/A
Device Problems Use of Device Problem (1670); Compatibility Problem (2960)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/03/2022
Event Type  malfunction  
Manufacturer Narrative
Medical product: allofit alloclassic shl 48/gg; catalog#: 4243; lot#: 3065267, fitmore, hip stem, uncemented, b/5, taper 12/14; catalog#: 01.00551.205; lot#: 3064594, illegible biolox delta ceramic femoral head, illegible durasul alpha insert.The manufacturer did not receive x-rays, or other source documents for review.The manufacturer did not receive the device for investigation.The lot number of the device was received.The device history records will be reviewed during investigation.A cause for this specific event cannot be ascertained from the information provided.As soon as supplemental information becomes available an updated report will be submitted.Zimmer biomet¿s reference number of this file is (b)(4).
 
Event Description
It was reported that during surgery, after inserting the allofit acetabulum, carefully visualising the rims and correctly seating the plug, it was not possible to insert a durasul cup.The surgeron made three attempts, then was forced to use a new durasul cup which sat immediately and firmly in the acetabulum.
 
Manufacturer Narrative
Product has been received by zimmer biomet and the investigation has been completed.Investigation and conclusion: reported event: during surgery, after inserting the allofit acetabulum, carefully visualizing the rims and correctly seating the plug, it was not possible to insert a durasul gg/32 cup.The surgeon made three attempts, then was forced to use a new durasul gg/32, which sat immediately and firmly in the acetabulum.Patient involved.No delay.Harm: s1 - no patient, user, or other stakeholder harm.Hazardous situation: implant breaks or becomes damaged and non-functional during surgical procedure, but is replaced intraoperatively before completing implantation.Product evaluation: visual examination: only the durasul liner was returned for investigation.The visual examination shows that the liner has scratches, nicks and indentations on the surface.It has a deformed and indented pole peg, as well as deformations.In addition, there are pin imprints visible.The articulation surface has some scratches, but are otherwise inconspicuous.Review surgical technique: surgical technique: if the liner can still be rotated after light impaction, this indicates mispositionning, nonconcentric, or soft tissues interference between the liner and the shell surfaces.In such situation, remove the liner, clean both surfaces and introduce the liner back into the shell, making sure it is properly centered and repeat the seating procedure.No further due diligence required as all required information to support the conclusion is available or was already requested.Devices are used for treatment.The product combination was approved by zimmer biomet.Review of complaint history identified additional similar complaints for the reported item and no additional complaints for the reported part and lot combination related to the event.Medical records were not provided.The quality records (dhr) show that all specified characteristics have met the specifications valid at the time of production.Therefore, the investigation did not identify a nonconformance or a complaint out of box (coob).In conclusion, it can be assumed that the insert was in a slightly tilted position within the shell prior or during impaction leading to the assembly issue.However, based on the given information and the results of the investigation, we were not able to identify a specific root cause for this issue.No corrective actions, preventive actions, or field actions resulted after investigation of this event.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
This follow-up report is being submitted to relay additional information.Investigation has been completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURASUL, ALPHA INSERT, GG/32
Type of Device
INTER-OP DURASUL ACETAB INSE/COCR FEMOR
Manufacturer (Section D)
ZIMMER SWITZERLAND MANUFACTURING GMBH
sulzer allee 8
sulzer industrie park
winterthur 8404
SZ  8404
Manufacturer (Section G)
ZIMMER SWITZERLAND MANUFACTURING GMBH
sulzer allee 8
sulzer industrie park
winterthur 8404
SZ   8404
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key13384822
MDR Text Key284623620
Report Number0009613350-2022-00046
Device Sequence Number1
Product Code LPH
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
K993259
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number01.00013.407
Device Lot Number3060645
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/04/2022
Initial Date FDA Received01/28/2022
Supplement Dates Manufacturer Received04/19/2022
Supplement Dates FDA Received04/20/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Treatment
SEE H10 NARRATIVE
Patient SexFemale
-
-